Cyclin A1 and gametogenesis in fertile and infertile patients: a potential new molecular diagnostic marker.

Standard

Cyclin A1 and gametogenesis in fertile and infertile patients: a potential new molecular diagnostic marker. / Schrader, Mark; Müller-Tidow, Carsten; Ravnik, Stuart; Müller, Markus; Schulze, Wolfgang; Diederichs, Sven; Serve, Hubert; Miller, Kurt.

in: HUM REPROD, Jahrgang 17, Nr. 9, 9, 2002, S. 2338-2343.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Schrader, M, Müller-Tidow, C, Ravnik, S, Müller, M, Schulze, W, Diederichs, S, Serve, H & Miller, K 2002, 'Cyclin A1 and gametogenesis in fertile and infertile patients: a potential new molecular diagnostic marker.', HUM REPROD, Jg. 17, Nr. 9, 9, S. 2338-2343. <http://www.ncbi.nlm.nih.gov/pubmed/12202422?dopt=Citation>

APA

Schrader, M., Müller-Tidow, C., Ravnik, S., Müller, M., Schulze, W., Diederichs, S., Serve, H., & Miller, K. (2002). Cyclin A1 and gametogenesis in fertile and infertile patients: a potential new molecular diagnostic marker. HUM REPROD, 17(9), 2338-2343. [9]. http://www.ncbi.nlm.nih.gov/pubmed/12202422?dopt=Citation

Vancouver

Schrader M, Müller-Tidow C, Ravnik S, Müller M, Schulze W, Diederichs S et al. Cyclin A1 and gametogenesis in fertile and infertile patients: a potential new molecular diagnostic marker. HUM REPROD. 2002;17(9):2338-2343. 9.

Bibtex

@article{ea9e356ddbe244279fb6ea2eed319d7e,
title = "Cyclin A1 and gametogenesis in fertile and infertile patients: a potential new molecular diagnostic marker.",
abstract = "BACKGROUND: The study aim was to evaluate cyclin A1 mRNA expression levels as a potential molecular diagnostic parameter in the work-up of testicular tissue from fertile versus infertile patients. METHODS: Cyclin A1 expression was quantified in 55 cryopreserved testicular tissue specimens by fluorescence real-time RT-PCR. A conventional histological work-up was performed concomitantly in all tissue specimens with additional semi-thin sectioning in all cases of non-obstructive azoospermia (n = 12), maturation arrest (n = 17) and Sertoli cell-only syndrome (SCOS; n = 9). RESULTS: The mean (+/- SD) normalized cyclin A1 expression (N(CyclinA1)) was 3.82 +/- 2.23 relative gene expression (RGE) in tissue specimens with normal spermatogenesis, and 0.625 +/- 0.221 RGE in those with maturation arrest at the level of early spermatids. Only minimal N(CyclinA1) was detected in tissue specimens with spermatogonia only or maturation arrest at the level of primary spermatocytes (0.005 +/- 0.008). Cyclin A1 expression was absent in the majority of SCOS specimens (0.002 +/- 0.002). CONCLUSIONS: These investigations suggested that cyclin A1 expression is altered in cases of spermatogenic disorders. Moreover, the level of cyclin A1 mRNA expression correlates with gametogenic disorders and seems well suited for a molecular-diagnostic classification supplementing the histopathological evaluation of spermatogenic disorders.",
author = "Mark Schrader and Carsten M{\"u}ller-Tidow and Stuart Ravnik and Markus M{\"u}ller and Wolfgang Schulze and Sven Diederichs and Hubert Serve and Kurt Miller",
year = "2002",
language = "Deutsch",
volume = "17",
pages = "2338--2343",
journal = "HUM REPROD",
issn = "0268-1161",
publisher = "Oxford University Press",
number = "9",

}

RIS

TY - JOUR

T1 - Cyclin A1 and gametogenesis in fertile and infertile patients: a potential new molecular diagnostic marker.

AU - Schrader, Mark

AU - Müller-Tidow, Carsten

AU - Ravnik, Stuart

AU - Müller, Markus

AU - Schulze, Wolfgang

AU - Diederichs, Sven

AU - Serve, Hubert

AU - Miller, Kurt

PY - 2002

Y1 - 2002

N2 - BACKGROUND: The study aim was to evaluate cyclin A1 mRNA expression levels as a potential molecular diagnostic parameter in the work-up of testicular tissue from fertile versus infertile patients. METHODS: Cyclin A1 expression was quantified in 55 cryopreserved testicular tissue specimens by fluorescence real-time RT-PCR. A conventional histological work-up was performed concomitantly in all tissue specimens with additional semi-thin sectioning in all cases of non-obstructive azoospermia (n = 12), maturation arrest (n = 17) and Sertoli cell-only syndrome (SCOS; n = 9). RESULTS: The mean (+/- SD) normalized cyclin A1 expression (N(CyclinA1)) was 3.82 +/- 2.23 relative gene expression (RGE) in tissue specimens with normal spermatogenesis, and 0.625 +/- 0.221 RGE in those with maturation arrest at the level of early spermatids. Only minimal N(CyclinA1) was detected in tissue specimens with spermatogonia only or maturation arrest at the level of primary spermatocytes (0.005 +/- 0.008). Cyclin A1 expression was absent in the majority of SCOS specimens (0.002 +/- 0.002). CONCLUSIONS: These investigations suggested that cyclin A1 expression is altered in cases of spermatogenic disorders. Moreover, the level of cyclin A1 mRNA expression correlates with gametogenic disorders and seems well suited for a molecular-diagnostic classification supplementing the histopathological evaluation of spermatogenic disorders.

AB - BACKGROUND: The study aim was to evaluate cyclin A1 mRNA expression levels as a potential molecular diagnostic parameter in the work-up of testicular tissue from fertile versus infertile patients. METHODS: Cyclin A1 expression was quantified in 55 cryopreserved testicular tissue specimens by fluorescence real-time RT-PCR. A conventional histological work-up was performed concomitantly in all tissue specimens with additional semi-thin sectioning in all cases of non-obstructive azoospermia (n = 12), maturation arrest (n = 17) and Sertoli cell-only syndrome (SCOS; n = 9). RESULTS: The mean (+/- SD) normalized cyclin A1 expression (N(CyclinA1)) was 3.82 +/- 2.23 relative gene expression (RGE) in tissue specimens with normal spermatogenesis, and 0.625 +/- 0.221 RGE in those with maturation arrest at the level of early spermatids. Only minimal N(CyclinA1) was detected in tissue specimens with spermatogonia only or maturation arrest at the level of primary spermatocytes (0.005 +/- 0.008). Cyclin A1 expression was absent in the majority of SCOS specimens (0.002 +/- 0.002). CONCLUSIONS: These investigations suggested that cyclin A1 expression is altered in cases of spermatogenic disorders. Moreover, the level of cyclin A1 mRNA expression correlates with gametogenic disorders and seems well suited for a molecular-diagnostic classification supplementing the histopathological evaluation of spermatogenic disorders.

M3 - SCORING: Zeitschriftenaufsatz

VL - 17

SP - 2338

EP - 2343

JO - HUM REPROD

JF - HUM REPROD

SN - 0268-1161

IS - 9

M1 - 9

ER -